Compare ANTX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANTX | INTT |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | United States | United States |
| Employees | N/A | 407 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 148.4M |
| IPO Year | 2022 | 1997 |
| Metric | ANTX | INTT |
|---|---|---|
| Price | $4.93 | $11.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 194.6K | 96.8K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $66,801,000.00 |
| Revenue This Year | N/A | $15.82 |
| Revenue Next Year | N/A | $9.10 |
| P/E Ratio | ★ N/A | $195.17 |
| Revenue Growth | N/A | ★ 66.06 |
| 52 Week Low | $1.00 | $7.07 |
| 52 Week High | $7.19 | $20.00 |
| Indicator | ANTX | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 46.23 |
| Support Level | $3.91 | $11.17 |
| Resistance Level | $5.15 | $11.83 |
| Average True Range (ATR) | 0.34 | 0.47 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 21.49 | 60.98 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.